DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.43−0.45 (-3.79%)
Close on Nov 12, 2026Market cap $718.69MP/E –Yield –
DBV Technologies pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
DBV Technologies's pe ratio was 1.9× on Jan 31, 2025, against 0.4× a year earlier. Over the last 2 years it ranged from 0.2× to 1.9×, with a median of 0.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 1.9× | +0.5 |
| 2024 | Dec 31, 2024 | 1.4× | +1.0 |
| 2023 | Dec 29, 2023 | 0.4× | – |
See a number that looks wrong?